Equity to Asset ratio is calculated as total stockholders equity divided by total asset. BioAdaptives's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $-1.65 Mil. BioAdaptives's Total Assets for the quarter that ended in Dec. 2023 was $0.10 Mil.
Therefore, BioAdaptives's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was -15.84.
The historical rank and industry rank for BioAdaptives's Equity-to-Asset or its related term are showing as below:
BDPT'
s Equity-to-Asset Range Over the Past 10 Years
Min: -72.58 Med: -29 Max: -6.31
Current: -15.84
During the past 9 years, the highest Equity to Asset Ratio of BioAdaptives was -6.31. The lowest was -72.58. And the median was -29.00.
BDPT's Equity-to-Asset is ranked worse than 99.37% of 1918
companies
in the Consumer Packaged Goods industry
Industry Median: 0.54
vs BDPT: -15.84
BioAdaptives Equity-to-Asset Historical Data
The historical data trend for BioAdaptives's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BioAdaptives's Equity-to-Asset
For the Packaged Foods subindustry, BioAdaptives's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioAdaptives's Equity-to-Asset Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, BioAdaptives's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where BioAdaptives's Equity-to-Asset falls into.
BioAdaptives Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
BioAdaptives's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
BioAdaptives Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of BioAdaptives's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
BioAdaptives Inc is engaged in investigating, marketing and distributing natural plant- and algal-based products and medical devices that improve health and wellness for humans and animals, with an emphasis on pain relief, anti-viral function, and anti-aging properties. Its products include dietary supplements using natural ingredients and proprietary methods of optimizing the availability of nutrients in foods and beverages. The human products are designed to aid memory, cognition and focus; assist in sleep and fatigue reduction; provide pain relief and healing; and improve overall emotional and physical wellness. Its product lines include PluriPain, PrimiLungs, SleepEZ, MindNMemory, Cell Rejuven and ProteinNMore.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BDPT has been successfully added to your 